RxDoctor Payments Data

Kent Renaud, DPM

Podiatrist · Rapid City, SDNPI 1477523512

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 87.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $586 and has fallen 94.2% since, to $34 in 2025.

$704in general payments, 2019–2025

Across 20 payments — averaging $35.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$613
  • Smith+Nephew$41
  • Abbott$38
  • Osiris Therapeutics Inc.$11

What the payments were for

  • Food & beverage$704100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker14$613
Smith+Nephew3$41
Abbott2$38
Osiris Therapeutics Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few podiatrist providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$485,307
Medicare patients
436
Services billed
2,674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$336
Ciprofloxacin Hcl17$176
Ondansetron Hcl37$145
Cephalexin22$103
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$91

Paid to pharmacies, not to this prescriber.

Other podiatrist in Rapid City

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →